RESONANCE HEALTH LIMITED - Announcements

Market Cap $35.75M Add to my watchlist

Healthcare Medical Devices

Resonance Health Limited is an Australia-based MedTech company. The Company specializes... Resonance Health Limited is an Australia-based MedTech company. The Company specializes in the development and delivery of non-invasive medical imaging software and services. The Company is engaged in the development and commercialization of software-as-medical-device (SaMD) technologies and services for the quantitative analysis of radiological images in a regulated and quality-controlled environment. Its portfolio includes Core Lab and artificial intelligence (AI) powered products to partner with clinicians and radiologists for diagnosis, and management of patients in a variety of clinical settings. Its core SaMD product is FerriScan, a non-invasive liver analysis technology used for the assessment of iron in the liver. The Company's other SaMDs include Cardiac T2, for the assessment of iron in the heart, and HepaFat-Scan for the assessment of fat in and around the liver. The Company also has several AI-assisted SaMDs, including FerriSmart, HepaFat-AI, and LiverSmart.More

Announcements

Filter Results

All Price Sensitive Only

RHT	Change of Director's Interest Notice		29/05/18	68.66KB	Share
RHT	Additional Info. in relation to 4 May 2018 announcement	PRICE SENSITIVE	04/05/18	90.5KB	Share
RHT	Resonance Deal to distribute Diabetic Retinopathy AI tool	PRICE SENSITIVE	04/05/18	285.25KB	Share
RHT	Appendix 4C - quarterly	PRICE SENSITIVE	23/04/18	137.58KB	Share
RHT	Customer Newsletter - March 2018		23/03/18	640.57KB	Share
RHT	Appendix 3B		09/03/18	2.21MB	Share
RHT	Change of Director's Interest Notice		07/03/18	68.05KB	Share
RHT	Director Appointment		28/02/18	153.63KB	Share
RHT	Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/18	248.22KB	Share
RHT	Appointment of CEO	PRICE SENSITIVE	23/02/18	250.44KB	Share
RHT	RHT Develops new assessment for the screening of NASH	PRICE SENSITIVE	20/02/18	246.04KB	Share
RHT	Change of Director's Interest Notice		15/02/18	68.56KB	Share
RHT	Resonance Health contracted for new clinical trial	PRICE SENSITIVE	13/02/18	367.74KB	Share
RHT	R&D Tax Incentive	PRICE SENSITIVE	09/02/18	246.35KB	Share
RHT	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/18	557.36KB	Share
RHT	FerriScan contracted for two new Clinical Trials	PRICE SENSITIVE	12/01/18	240.44KB	Share
RHT	Customer Newsletter - December 2017		20/12/17	837.2KB	Share
RHT	Multi Centre testing commences for AI solution	PRICE SENSITIVE	15/12/17	249KB	Share
RHT	Change of Director's Interest Notice		11/12/17	67.54KB	Share
RHT	Appendix 3Y Change of Director's Interest Notice		01/12/17	68.54KB	Share
RHT	Company Secretary Appointment/Resignation		30/11/17	352.92KB	Share
RHT	Results of Meeting		23/11/17	84.92KB	Share
RHT	Change Substantial Shareholder Notification		20/11/17	168.7KB	Share
RHT	Appendix 3Y Change of Director's Interest Notice		20/11/17	227.75KB	Share
RHT	Appendix 4C - quarterly	PRICE SENSITIVE	31/10/17	523.11KB	Share
RHT	Annual Report to shareholders		23/10/17	19.25MB	Share
RHT	Investor Presentation		19/10/17	13.83MB	Share
RHT	Notice of General Meeting/Proxy Form		17/10/17	357.08KB	Share
RHT	Collaborative Partnership to develop new AI Diagnostic tools		17/10/17	214.48KB	Share
RHT	Beta Testing Success for Cloud-Based A.I. Prototype	PRICE SENSITIVE	17/10/17	248.9KB	Share
RHT	Customer Newsletter		02/10/17	732.91KB	Share
RHT	Appendix 4G and Corporate Governance Statement		28/09/17	396.87KB	Share
RHT	Annual Report 2017		28/09/17	576.85KB	Share
RHT	Preliminary Final Report	PRICE SENSITIVE	30/08/17	293.62KB	Share
RHT	Beta Testing Commences for Cloud-Based A.I Prototype	PRICE SENSITIVE	21/08/17	213.96KB	Share
RHT	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/17	616.23KB	Share
RHT	Equity Research Update Report Released		17/07/17	242.94KB	Share
RHT	New Registered Office and Business Address		05/07/17	205.37KB	Share
RHT	Final Director's Interest Notice		03/07/17	194.25KB	Share
RHT	Customer Newsletter - June 2017		30/06/17	682.53KB	Share
RHT	Resignation of Non-Executive Director		29/06/17	202.51KB	Share
RHT	Bone Marrow Iron Assessment Launch	PRICE SENSITIVE	22/06/17	349.96KB	Share
RHT	Leading Patient NGO Endorses FerriScan and AI Technology	PRICE SENSITIVE	21/06/17	643.43KB	Share
RHT	Artificial Intelligence Solution for Emerging Markets	PRICE SENSITIVE	14/06/17	489.19KB	Share
RHT	Quarterly Report	PRICE SENSITIVE	28/04/17	597.15KB	Share
RHT	FerriScan not impacted by Fatty Liver		18/04/17	336.97KB	Share
RHT	Evidence Building for HepaFat-Scan	PRICE SENSITIVE	12/04/17	433.56KB	Share
RHT	Appendix 3Y Panton		05/04/17	227.66KB	Share
RHT	Customer Newsletter - March 2017		30/03/17	618.04KB	Share
RHT	Cancer Survivor Campaign Update	PRICE SENSITIVE	23/03/17	330.52KB	Share
RHT	Updated Securities Trading Policy		01/03/17	491.9KB	Share
RHT	Half year report	PRICE SENSITIVE	28/02/17	453.88KB	Share
RHT	Change in substantial holding		09/02/17	142.81KB	Share
RHT	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/17	529.06KB	Share
RHT	Maylasian NAFLD - Diabetes Study	PRICE SENSITIVE	12/01/17	353.91KB	Share
RHT	Customer Newsletter December 2016		23/12/16	977.45KB	Share
RHT	FerriScan use showcased at ASH conference		15/12/16	354.78KB	Share
RHT	Equity Research Report Released		01/12/16	235.22KB	Share
RHT	Initial Director's Interest Notice		28/11/16	196.45KB	Share
RHT	Results of Meeting		24/11/16	307.97KB	Share
RHT	Annual General Meeting Presentation		24/11/16	531.97KB	Share
RHT	Director Appointment		16/11/16	331.36KB	Share
RHT	Results Recommending Use of FerriScan in Sickle Cell Disease	PRICE SENSITIVE	10/11/16	345.17KB	Share
RHT	Change in substantial holding		09/11/16	144.91KB	Share
RHT	Appendix 4C - quarterly-RHT.AX	PRICE SENSITIVE	28/10/16	579.01KB	Share
RHT	Notice of Annual General Meeting/Proxy Form-RHT.AX		24/10/16	181.58KB	Share
RHT	Annual Report to shareholders-RHT.AX		24/10/16	1.88MB	Share
RHT	Resonance Health commences involvement in diabetes study-RHT.AX	PRICE SENSITIVE	13/10/16	341.98KB	Share
RHT	Customer Newsletter-RHT.AX		30/09/16	732.13KB	Share
RHT	Appendix 4G-RHT.AX		29/09/16	223.4KB	Share
RHT	Full Year Statutory Accounts-RHT.AX		29/09/16	553.18KB	Share
RHT	Bone Marrow Iron - Regulatory Submission-RHT.AX	PRICE SENSITIVE	23/09/16	247.96KB	Share
RHT	Becoming a substantial holder-RHT.AX		13/09/16	139.38KB	Share
RHT	Expansion of Involvement in Pharmaceutical Clinical Trial-RHT.AX	PRICE SENSITIVE	07/09/16	338.9KB	Share
RHT	Appendix 3B Issue of Employee Shares-RHT.AX		31/08/16	472.65KB	Share
RHT	Preliminary Final Report-RHT.AX	PRICE SENSITIVE	30/08/16	326.58KB	Share
RHT	Correction of Link - HepaFat-Scan International Publication-RHT.AX		11/08/16	249.55KB	Share
RHT	HepaFat-Scan International Scientific Journal-RHT.AX	PRICE SENSITIVE	11/08/16	85.48KB	Share
RHT	Appendix 4C - quarterly-RHT.AX	PRICE SENSITIVE	26/07/16	398.41KB	Share
RHT	Customer News letter-RHT.AX		29/06/16	650.36KB	Share
RHT	Appendix 3B-RHT.AX		29/06/16	472.9KB	Share
RHT	Operational Update-RHT.AX	PRICE SENSITIVE	14/06/16	290.21KB	Share
RHT	New UK Standards recommend FerriScan-RHT.AX	PRICE SENSITIVE	30/05/16	344.43KB	Share
RHT	Appendix 4C Quarterly Cashflow Report-RHT.AX	PRICE SENSITIVE	29/04/16	463.72KB	Share
RHT	Completion Minimum Holding Share Sale-RHT.AX		20/04/16	308.43KB	Share
RHT	Second and Final Notice - Minimum Holding Share Sale-RHT.AX		05/04/16	401.33KB	Share
RHT	Newsletter		31/03/16	717.46KB	Share
RHT	Half Year Accounts	PRICE SENSITIVE	25/02/16	502.11KB	Share
RHT	Minimum Holding Share Sale		23/02/16	454.84KB	Share
RHT	Appendix 4C - quarterly	PRICE SENSITIVE	01/02/16	375.51KB	Share
RHT	Customer Newsletter		22/12/15	722.99KB	Share
RHT	Results of AGM		20/11/15	302.38KB	Share
RHT	AGM Presentation		20/11/15	395.82KB	Share
RHT	Appendix 4C - quarterly	PRICE SENSITIVE	29/10/15	386.74KB	Share
RHT	Annual Report to shareholders		20/10/15	7.09MB	Share
RHT	Notice of Annual General Meeting/Proxy Form		20/10/15	183.08KB	Share
RHT	AASLD Abstract		02/10/15	369.12KB	Share
RHT	Customer News Letter		30/09/15	4.55MB	Share
RHT	Appendix 4G		24/09/15	207.41KB	Share
RHT	Full Year Statutory Accounts		24/09/15	1.01MB	Share

RHT Change of Director's Interest Notice
29/05/18		68.66KB	Share
RHT Additional Info. in relation to 4 May 2018 announcement
04/05/18	PRICE SENSITIVE	90.5KB	Share
RHT Resonance Deal to distribute Diabetic Retinopathy AI tool
04/05/18	PRICE SENSITIVE	285.25KB	Share
RHT Appendix 4C - quarterly
23/04/18	PRICE SENSITIVE	137.58KB	Share
RHT Customer Newsletter - March 2018
23/03/18		640.57KB	Share
RHT Appendix 3B
09/03/18		2.21MB	Share
RHT Change of Director's Interest Notice
07/03/18		68.05KB	Share
RHT Director Appointment
28/02/18		153.63KB	Share
RHT Half Yearly Report and Accounts
26/02/18	PRICE SENSITIVE	248.22KB	Share
RHT Appointment of CEO
23/02/18	PRICE SENSITIVE	250.44KB	Share
RHT RHT Develops new assessment for the screening of NASH
20/02/18	PRICE SENSITIVE	246.04KB	Share
RHT Change of Director's Interest Notice
15/02/18		68.56KB	Share
RHT Resonance Health contracted for new clinical trial
13/02/18	PRICE SENSITIVE	367.74KB	Share
RHT R&D Tax Incentive
09/02/18	PRICE SENSITIVE	246.35KB	Share
RHT Appendix 4C - quarterly
31/01/18	PRICE SENSITIVE	557.36KB	Share
RHT FerriScan contracted for two new Clinical Trials
12/01/18	PRICE SENSITIVE	240.44KB	Share
RHT Customer Newsletter - December 2017
20/12/17		837.2KB	Share
RHT Multi Centre testing commences for AI solution
15/12/17	PRICE SENSITIVE	249KB	Share
RHT Change of Director's Interest Notice
11/12/17		67.54KB	Share
RHT Appendix 3Y Change of Director's Interest Notice
01/12/17		68.54KB	Share
RHT Company Secretary Appointment/Resignation
30/11/17		352.92KB	Share
RHT Results of Meeting
23/11/17		84.92KB	Share
RHT Change Substantial Shareholder Notification
20/11/17		168.7KB	Share
RHT Appendix 3Y Change of Director's Interest Notice
20/11/17		227.75KB	Share
RHT Appendix 4C - quarterly
31/10/17	PRICE SENSITIVE	523.11KB	Share
RHT Annual Report to shareholders
23/10/17		19.25MB	Share
RHT Investor Presentation
19/10/17		13.83MB	Share
RHT Notice of General Meeting/Proxy Form
17/10/17		357.08KB	Share
RHT Collaborative Partnership to develop new AI Diagnostic tools
17/10/17		214.48KB	Share
RHT Beta Testing Success for Cloud-Based A.I. Prototype
17/10/17	PRICE SENSITIVE	248.9KB	Share
RHT Customer Newsletter
02/10/17		732.91KB	Share
RHT Appendix 4G and Corporate Governance Statement
28/09/17		396.87KB	Share
RHT Annual Report 2017
28/09/17		576.85KB	Share
RHT Preliminary Final Report
30/08/17	PRICE SENSITIVE	293.62KB	Share
RHT Beta Testing Commences for Cloud-Based A.I Prototype
21/08/17	PRICE SENSITIVE	213.96KB	Share
RHT Appendix 4C - quarterly
31/07/17	PRICE SENSITIVE	616.23KB	Share
RHT Equity Research Update Report Released
17/07/17		242.94KB	Share
RHT New Registered Office and Business Address
05/07/17		205.37KB	Share
RHT Final Director's Interest Notice
03/07/17		194.25KB	Share
RHT Customer Newsletter - June 2017
30/06/17		682.53KB	Share
RHT Resignation of Non-Executive Director
29/06/17		202.51KB	Share
RHT Bone Marrow Iron Assessment Launch
22/06/17	PRICE SENSITIVE	349.96KB	Share
RHT Leading Patient NGO Endorses FerriScan and AI Technology
21/06/17	PRICE SENSITIVE	643.43KB	Share
RHT Artificial Intelligence Solution for Emerging Markets
14/06/17	PRICE SENSITIVE	489.19KB	Share
RHT Quarterly Report
28/04/17	PRICE SENSITIVE	597.15KB	Share
RHT FerriScan not impacted by Fatty Liver
18/04/17		336.97KB	Share
RHT Evidence Building for HepaFat-Scan
12/04/17	PRICE SENSITIVE	433.56KB	Share
RHT Appendix 3Y Panton
05/04/17		227.66KB	Share
RHT Customer Newsletter - March 2017
30/03/17		618.04KB	Share
RHT Cancer Survivor Campaign Update
23/03/17	PRICE SENSITIVE	330.52KB	Share
RHT Updated Securities Trading Policy
01/03/17		491.9KB	Share
RHT Half year report
28/02/17	PRICE SENSITIVE	453.88KB	Share
RHT Change in substantial holding
09/02/17		142.81KB	Share
RHT Appendix 4C - quarterly
31/01/17	PRICE SENSITIVE	529.06KB	Share
RHT Maylasian NAFLD - Diabetes Study
12/01/17	PRICE SENSITIVE	353.91KB	Share
RHT Customer Newsletter December 2016
23/12/16		977.45KB	Share
RHT FerriScan use showcased at ASH conference
15/12/16		354.78KB	Share
RHT Equity Research Report Released
01/12/16		235.22KB	Share
RHT Initial Director's Interest Notice
28/11/16		196.45KB	Share
RHT Results of Meeting
24/11/16		307.97KB	Share
RHT Annual General Meeting Presentation
24/11/16		531.97KB	Share
RHT Director Appointment
16/11/16		331.36KB	Share
RHT Results Recommending Use of FerriScan in Sickle Cell Disease
10/11/16	PRICE SENSITIVE	345.17KB	Share
RHT Change in substantial holding
09/11/16		144.91KB	Share
RHT Appendix 4C - quarterly-RHT.AX
28/10/16	PRICE SENSITIVE	579.01KB	Share
RHT Notice of Annual General Meeting/Proxy Form-RHT.AX
24/10/16		181.58KB	Share
RHT Annual Report to shareholders-RHT.AX
24/10/16		1.88MB	Share
RHT Resonance Health commences involvement in diabetes study-RHT.AX
13/10/16	PRICE SENSITIVE	341.98KB	Share
RHT Customer Newsletter-RHT.AX
30/09/16		732.13KB	Share
RHT Appendix 4G-RHT.AX
29/09/16		223.4KB	Share
RHT Full Year Statutory Accounts-RHT.AX
29/09/16		553.18KB	Share
RHT Bone Marrow Iron - Regulatory Submission-RHT.AX
23/09/16	PRICE SENSITIVE	247.96KB	Share
RHT Becoming a substantial holder-RHT.AX
13/09/16		139.38KB	Share
RHT Expansion of Involvement in Pharmaceutical Clinical Trial-RHT.AX
07/09/16	PRICE SENSITIVE	338.9KB	Share
RHT Appendix 3B Issue of Employee Shares-RHT.AX
31/08/16		472.65KB	Share
RHT Preliminary Final Report-RHT.AX
30/08/16	PRICE SENSITIVE	326.58KB	Share
RHT Correction of Link - HepaFat-Scan International Publication-RHT.AX
11/08/16		249.55KB	Share
RHT HepaFat-Scan International Scientific Journal-RHT.AX
11/08/16	PRICE SENSITIVE	85.48KB	Share
RHT Appendix 4C - quarterly-RHT.AX
26/07/16	PRICE SENSITIVE	398.41KB	Share
RHT Customer News letter-RHT.AX
29/06/16		650.36KB	Share
RHT Appendix 3B-RHT.AX
29/06/16		472.9KB	Share
RHT Operational Update-RHT.AX
14/06/16	PRICE SENSITIVE	290.21KB	Share
RHT New UK Standards recommend FerriScan-RHT.AX
30/05/16	PRICE SENSITIVE	344.43KB	Share
RHT Appendix 4C Quarterly Cashflow Report-RHT.AX
29/04/16	PRICE SENSITIVE	463.72KB	Share
RHT Completion Minimum Holding Share Sale-RHT.AX
20/04/16		308.43KB	Share
RHT Second and Final Notice - Minimum Holding Share Sale-RHT.AX
05/04/16		401.33KB	Share
RHT Newsletter
31/03/16		717.46KB	Share
RHT Half Year Accounts
25/02/16	PRICE SENSITIVE	502.11KB	Share
RHT Minimum Holding Share Sale
23/02/16		454.84KB	Share
RHT Appendix 4C - quarterly
01/02/16	PRICE SENSITIVE	375.51KB	Share
RHT Customer Newsletter
22/12/15		722.99KB	Share
RHT Results of AGM
20/11/15		302.38KB	Share
RHT AGM Presentation
20/11/15		395.82KB	Share
RHT Appendix 4C - quarterly
29/10/15	PRICE SENSITIVE	386.74KB	Share
RHT Annual Report to shareholders
20/10/15		7.09MB	Share
RHT Notice of Annual General Meeting/Proxy Form
20/10/15		183.08KB	Share
RHT AASLD Abstract
02/10/15		369.12KB	Share
RHT Customer News Letter
30/09/15		4.55MB	Share
RHT Appendix 4G
24/09/15		207.41KB	Share
RHT Full Year Statutory Accounts
24/09/15		1.01MB	Share

REFRESH

First 2 3 4

(20min delay)
Last 8.0¢		Change 0.000(0.00%)		Mkt cap ! $35.75M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
1	81906	7.9¢

Sellers (Offers)

Price($)	Vol.	No.
8.1¢	70000	1

View Market Depth

No.	Vol.	Price($)
1	81906	0.079
1	6840	0.077
1	26078	0.075
1	65000	0.073
1	68200	0.071

Price($)	Vol.	No.
0.081	70000	1
0.082	76975	2
0.083	80000	1
0.085	28708	2
0.086	34482	1

Last trade - 10.06am 08/05/2024 (20 minute delay)

RHT (ASX) Chart

Day chart unavailable

RESONANCE HEALTH LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories